Fingerprint
Dive into the research topics of 'A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically